Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerro-alloy Resources Limited Regulatory News (FAR)

Share Price Information for Ferro-alloy Resources Limited (FAR)

Share Price is delayed by 15 minutes
Get Live Data
4.90    0.00 (0.00%)
Bid:
4.80
Ask:
5.00
Spread: 0.20 (4.167%)
Market Cap: £28.80m
FAR Live PriceLast checked at - London Stock Exchange

Intraday Ferro-alloy Resources Limited Share Chart

Total Voting Rights

30 Nov 2023 07:00

RNS Number : 1232V
Ferro-Alloy Resources Limited
30 November 2023
 

 

30 November 2023

 

Ferro-Alloy Resources Limited

("Ferro-Alloy" or the "Group" or the "Company")

 

Total Voting Rights

 

Ferro-Alloy Resources Limited (LSE:FAR), the vanadium producer and developer of the large Balasausqandiq vanadium deposit in Southern Kazakhstan, announces that the issued share capital of the Company as at the date of this announcement comprises 483,222,238 ordinary shares, with none held in treasury, and therefore, the total number of ordinary shares in the Company with voting rights is 483,222,238.

This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the applicable legal and regulatory requirements.

**ENDS**

 

For further information, visit www.ferro-alloy.com  or contact:

 

Ferro-Alloy Resources Limited

Nick Bridgen (CEO) / William Callewaert (CFO)

info@ferro-alloy.com

 

Shore Capital 

(Joint Corporate Broker)

 

Liberum Capital Limited

(Joint Corporate Broker)

Toby Gibbs/Lucy Bowden

 

 

Scott Mathieson/Kane Collings

 

+44 207 408 4090

 

 

+44 20 3100 2000

 

St Brides Partners Limited

(Financial PR & IR Adviser)

Catherine Leftley/Ana Ribeiro

+44 207 236 1177

 

About Ferro-Alloy Resources Limited:

The Company's operations are all located at the Balasausqandiq deposit in Kyzylordinskoye Oblast in the South of Kazakhstan. Currently the Company has two main business activities:

a) the high grade Balasausqandiq vanadium project (the "Project"); and

b) an existing vanadium concentrate processing operation (the "Existing Operation")

Balasausqandiq is a very large deposit, with vanadium as the principal product together with several by-products. Owing to the nature of the ore, the capital and operating costs of development are very much lower than for other vanadium projects.

The most recent mineral resource estimate for ore-body one (of seven) provided an Indicated Mineral Resource of 32.9 million tonnes at a mean grade of 0.62% V2O5 equating to 203,364 contained tonnes of vanadium pentoxide ("V2O5"). In the system of reserve estimation used in Kazakhstan the reserves are estimated to be over 70m tonnes in ore-bodies 1 to 5 but this does not include the full depth of ore-bodies 2 to 5 or the remaining ore-bodies which remain substantially unexplored. 

The Project will be developed in two stages, Stage 1 and Stage 2, treating 1m tonnes per year and an additional 3m tonnes per year. Production will be some 5,600 tonnes of V2O5 from Stage 1, rising to 22,400 tonnes V2O5 after Stage 2 is commissioned.

There is an existing concentrate processing operation at the site of the Balasausqandiq deposit. The production facilities were originally created from a 15,000 tonnes per year pilot plant which was then expanded and adapted to recover vanadium, molybdenum and nickel from purchased concentrates. 

The existing operation is located on the same site and uses some of the same infrastructure as the Project, but is a separate operation which will continue in parallel with the development and operation of the Project.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBRBDBSDDDGXC
Date   Source Headline
28th Sep 20217:00 amRNSInterim Results
22nd Sep 202111:15 amRNSProduction of ferro-molybdenum &vanadium pentoxide
22nd Sep 20217:00 amRNSProduction of ferro-molybdenum and ferro-vanadium
13th Sep 20217:00 amRNSElectrolyte Patent Received
24th Aug 20214:35 pmRNSPrice Monitoring Extension
28th Jun 202111:05 amRNSSecond Price Monitoring Extn
28th Jun 202111:00 amRNSPrice Monitoring Extension
28th Jun 20217:05 amRNSFurther Investment of US$7 million by Vision Blue
28th Jun 20217:00 amRNSFinal Results
7th Jun 20211:15 pmRNSVision Blue Investment Completion & Board Changes
2nd Jun 20219:05 amRNSSecond Price Monitoring Extn
2nd Jun 20219:00 amRNSPrice Monitoring Extension
1st Jun 20217:00 amRNSVision Blue Further Investment & Board Changes
7th May 20212:05 pmRNSSecond Price Monitoring Extn
7th May 20212:00 pmRNSPrice Monitoring Extension
7th May 202111:05 amRNSSecond Price Monitoring Extn
7th May 202111:00 amRNSPrice Monitoring Extension
6th Apr 20219:05 amRNSSecond Price Monitoring Extn
6th Apr 20219:00 amRNSPrice Monitoring Extension
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:36 pmRNSPrice Monitoring Extension
30th Mar 20217:00 amRNSUpdated Investor Presentation
29th Mar 202111:05 amRNSSecond Price Monitoring Extn
29th Mar 202111:00 amRNSPrice Monitoring Extension
26th Mar 202111:05 amRNSSecond Price Monitoring Extn
26th Mar 202111:00 amRNSPrice Monitoring Extension
25th Mar 20216:20 pmRNSHolding(s) in Company
24th Mar 20217:00 amRNSResult of Placing
23rd Mar 20214:35 pmRNSProposed Placing of Ordinary Shares
19th Mar 20214:41 pmRNSSecond Price Monitoring Extn
19th Mar 20214:35 pmRNSPrice Monitoring Extension
19th Mar 20212:05 pmRNSSecond Price Monitoring Extn
19th Mar 20212:00 pmRNSPrice Monitoring Extension
18th Mar 202112:00 pmRNSIssue of Equity
17th Mar 20219:05 amRNSSecond Price Monitoring Extn
17th Mar 20219:00 amRNSPrice Monitoring Extension
16th Mar 20214:40 pmRNSSecond Price Monitoring Extn
16th Mar 20214:36 pmRNSPrice Monitoring Extension
16th Mar 202112:45 pmRNSDirector Share Purchase
16th Mar 202111:05 amRNSSecond Price Monitoring Extn
16th Mar 202111:00 amRNSPrice Monitoring Extension
16th Mar 20219:06 amRNSSecond Price Monitoring Extn
16th Mar 20219:00 amRNSPrice Monitoring Extension
15th Mar 202111:05 amRNSSecond Price Monitoring Extn
15th Mar 202111:00 amRNSPrice Monitoring Extension
15th Mar 20219:05 amRNSSecond Price Monitoring Extn
15th Mar 20219:00 amRNSPrice Monitoring Extension
15th Mar 20217:01 amRNSStrategic Investment & Appointment of Chairman
15th Mar 20217:00 amRNS2020 Production & Operations Update Issue of Bonds
11th Jan 20217:00 amRNSIssue of Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.